Comparison of Ustekinumab and Vedolizumab Effectiveness in Perianal Crohn's Disease: A Retrospective Propensity Matched Cohort Study.

Saved in:
Bibliographic Details
Title: Comparison of Ustekinumab and Vedolizumab Effectiveness in Perianal Crohn's Disease: A Retrospective Propensity Matched Cohort Study.
Authors: Eldesouki MH; Department of Internal Medicine, New York Medical College at Saint Michael's Medical Center, Newark, NJ., Rabea E; Department of Internal Medicine, Alexandria Main University Hospital, Alexandria., Aldemerdash MA; Division of Gastroenterology and Hepatology, Sohag University Hospital, Sohag, Egypt., Tageldin O; Division of Gastroenterology and Hepatology, University of Tennessee Medical Center, Knoxville, TN., Seminerio J; Division of Gastroenterology and Hepatology, Advent Health, Orlando., Farraye FA; Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, FL., Hashash JG; Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, FL.
Source: Journal of clinical gastroenterology [J Clin Gastroenterol] 2026 May 28. Date of Electronic Publication: 2026 May 28.
Publication Type: Journal Article
Journal Info: Publisher: Wolters Kluwer Health, Inc Country of Publication: United States NLM ID: 7910017 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1539-2031 (Electronic) Linking ISSN: 01920790 NLM ISO Abbreviation: J Clin Gastroenterol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1539-2031
DOI:10.1097/MCG.0000000000002398